![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Premier Veterinary Group Plc | LSE:PVG | London | Ordinary Share | GB00BSZLMS59 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.50 | 32.00 | 37.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAKT
RNS Number : 8198H
Ark Therapeutics Group PLC
25 June 2013
Results of Annual General Meeting
London, UK, 25 June 2013: At the Annual General Meeting of Ark Therapeutics Group plc (LSE: AKT) held yesterday all resolutions as set out in the Notice of Meeting dated 20 May 2013 were duly passed. A summary of the proxy voting will be published in the Investor Relations section of the Company's website at www.arktherapeutics.com
A copy of the approved resolutions will be submitted to the National Storage Mechanism and will shortly be available for inspection at: www.hemscott.com/nsm.do
Enquiries:
Ark Therapeutics Group plc Tel: +44 (0)207 002 1005 Iain G Ross, Non-Executive Chairman David Venables, Non-Executive Director
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGSELFDIFDSESM
1 Year Premier Veterinary Chart |
1 Month Premier Veterinary Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions